ANR
Asset Logo

Anatara Lifesciences Ltd

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿงฌ BIOTECHNOLOGY

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-16.48%
Annual Growth

5 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

0
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Anatara Lifesciences Ltd. engages in the development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. The company is headquartered in Adelaide, South Australia. The company went IPO on 2014-10-16. The firm is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.

๐Ÿ“ˆ Performance

Price History

-80.69%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.06

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in ANR

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in ANR

N/A
ANR investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in ANR also invest in...

Want more shares? Try these...

AusNet Services Holdings Pty Ltd

ANVHAA

Find Out More

Ansell Ltd. engages in the development, manufacture, distribution, and sale of gloves and protective personal equipment in the industrial and medical end markets. The company is headquartered in Richmond, Victoria and currently employs 15,951 full-time employees. The firm is an integrated manufacturer of personal protection equipment for healthcare and industrial workplaces. Its brands such as HyFlex, Ringers, MICROFLEX, TouchNTuff, GAMMEX, and AlphaTec. The firm is engaged in designing, developing, and manufacturing a range of hand, arm and body protection solutions and clothing. The firm operates through two segments: Healthcare Global Business Unit (GBU), and Industrial GBU. The Healthcare GBU segment is consists of surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single use industrial application gloves. The Industrial GBU segment comprises multi-use hand and body protection solutions for industrial worker environments and specialty applications. The firm operates other brands consists of the Kimtech, KleenGuard, The RightCycle Program, and APEX.

๐Ÿ™Œ Performance (5Yr p.a)

1.95%

๐Ÿ“Š Share price

$34.18 AUD

๐Ÿฉบ HEALTH CARE

๐Ÿƒ HIGH ESG SCORE

๐Ÿ•Š๏ธ SOCIALLY AWARE

โš–๏ธ HIGH GOVERNANCE

Advance Zinctek Ltd. manufactures aluminum oxide powder, zinc oxide dispersions and zinc oxide powder for the personal care sector. The Companyโ€™s Personal Care segment produces and distributes dispersions of mineral-only ultraviolet (UV) filters in cosmetic emollients used for sunscreen, skincare and pharmaceutical formulations, as well as alumina plate-like powders used for cosmetic applications. The company supplies cosmetic and pharmaceutical grade zinc oxide powder used in sunscreens and personal care products. Its products offer vegan natural zinc oxide powders, bulk sunscreens and dispersions. The Companyโ€™s products include Organic ZinClear XP53 Coconut; Organic ZinClear XP57 Coconut Alusion; Organic ZinClear XP57 Coconut Blended Alusion; Organic ZinClear XP50 Sunflower Alusion; Organic ZinClear XP55 Sunflower, and others. Its subsidiaries include Antaria Pty Ltd, Sunscreen Safety Testing Laboratory Pty Ltd and others.

๐Ÿ™Œ Performance (5Yr p.a)

-17.49%

๐Ÿ“Š Share price

$0.77 AUD

๐Ÿงช CHEMICALS

Compare
Add to watchlist